UMU logo

Welcome! 2nd Arctic Meeting on Clinical Tuberculosis, Umeå 22 March 2019

Mycobacterium NIH NIAD 2nd Arctic Meeting on Clinical Tuberculosis, Umeå!

22nd March, University Hospital of Umeå, Lecture hall Betula and Common Ground

On behalf of the Tuberculosis Center Arctic we welcome  you to attend the 2nd Arctic Meeting on Clinical Tuberculosis.!


This is a joint meeting for clinical TB researchers and staff working hands on with TB on a daily basis. There will be lectures, discussions, mingle and team-building activities. The language of the meeting is English.

WTBD2017 Logo FullColor RGB

The 2nd Arctic Meeting on Clinical Tuberculosis is part of the WORLD TB DAY 2019.

This year’s topics are:

  • Tuberculosis in Migrants
  • Pediatric Tuberculosis – A Holistic Approach to TB in the Family
  • Treatment Strategies and Outcome Measures for MDR TB

The Nordic EMBL Partnership welcomes Oliver Billker

Oliver Billker mpn[2018-12-08] Annabel Darby, Communication Officer for the Nordic EMBL Partnership for Molecular Medicine, interviewed Oliver Billker a few weeks ago. Read about his visions for MIMS, his research and life in Umeå.

Interview with Oliver Billker on
www.nordicemblpartnership.org

SciLifeLab Cryo-EM Course on Tomography - 1 ECTS

modv0000Welcome to an advanced course in CryoEM Tomography!

Organiser and collaborators:
The Cryo-EM Swedish National Facility - Umeå node

In collaboration with
- SciLifeLab
- CryoNet - the Nordic Network in cryo-EM
- The Laboratory for Molecular Infection Medicine Sweden (MIMS)
- Umeå Centre for Microbial Research (UCMR)

Date: 26-28th March 2019, 3 days

Two projects at Umeå University receive funding in international collaborations with the aim to stop antimicrobial resistant bacteria

VH portraitMIMS and UCMR Researchers are funded by the Swedish Research Council for their participation in International research collaborations in two research consortia funded within the European Joint Programming Initiative on Antimicrobial Resistance (JPIAMR). These are the only pojects that are funded in Sweden in this call.

[2018-10-30] MIMS Group Leader and UCMR Researcher Vasili Hauryliuk, Department of Molecular Biology, is part of the project “Development of novel ribosome-targeting antibiotics” with collaborators in Germany, France, Czech Republic and Italy. Under the lead of Daniel Wilson at the University of Hamburg, Germany, the collaborating laboratories will focus on discovering novel antibiotics which are targeted towards the ribosome, the cellular protein fabric, which is one of the major target of existing antibiotics.

footer all slides 2014-02-06

Copyright © 2019 by The Laboratory for Molecular Infection Medicine Sweden (MIMS). All rights reserved.